This compound is a steroidal intermediate used in the synthesis of fulvestrant, featuring an ester and an ether functional group with a long alkyl chain protected by a silyl ether.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 875573-60-7
(7R,8R,9S,10R,13S,14S,17S)-7-(9-Bromononyl)-13-methyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate
research compound
(7a,17b)-7-(9-Bromononyl)-estra-1,3,5(10)-triene-3,17-diol 17-acetate
pharmaceutical intermediate
(7a,17b)-7-(9-Bromononyl)estra-1,3,5(10)-triene-3,17-diol
pharmaceutical intermediate
(7a,17b)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)thio]nonyl]-estra-1,3,5(10)-triene-3,17-diol
pharmaceutical intermediate
Bis(3-(perfluoroethyl)-1-(9-bromononyl)propyl) thioether
pharmaceutical intermediate
(7a,17b)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)thio]nonyl]-estra-1,3,5(10)-triene-3,17-diol 17-acetate
pharmaceutical intermediate
Ethyl (Z)-3-[(6-amino-3,5-difluoro-2-pyridyl)amino]-2-(2,4,5-trifluorobenzoyl)prop-2-enoate
pharmaceutical intermediate
Ethyl 1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-7-(3-(isobutyryloxy)azetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate
pharmaceutical intermediate
[(7R,8R,9S,10R,13S,14S,17S)-7-[9-[tert-butyl(dimethyl)silyl]oxynonyl]-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
UZWBDRNDIWPAKA-QIXFLCTJSA-N
CC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@@H](CC4=CC(=O)CC[C@H]34)CCCCCCCCCO[Si](C)(C)C(C)(C)C)C
—